05/31/2024
1:38 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:40 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:42 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:43 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:05 PM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/19/2024
7:40 AM | Vir Biotechnology (Filer)
| Form ARS | |
|
04/19/2024
7:32 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/19/2024
7:35 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/18/2024
7:44 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
3:14 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:58 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:18 AM | Lee Sung (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:32 PM | Lee Sung (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:32 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:34 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:30 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:31 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:32 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
8:02 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:35 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
5:56 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:59 AM | STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G | |
01/23/2024
3:14 PM | BlackRock Inc. (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G/A | |
01/03/2024
1:47 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:33 PM | Vir Biotechnology (Filer)
| Form S-3ASR | |
11/03/2023
3:37 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
1:15 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
1:14 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
7:01 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
5:02 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
2:54 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:14 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
7:04 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
4:17 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
4:01 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Are You Positioned For The New Energy Goldrush? (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
06/15/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
3:30 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
8:00 PM | SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:58 PM | Horn Howard (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023
11:19 AM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
11:20 AM | Rice Steven J. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:25 PM | Ramasastry Saira (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:27 PM | Rice Steven J. (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
